This review provides a comprehensive overview of current knowledge regarding autophagy regulation in ovarian cancer, summarizes the structural and pharmacological characteristics of ginsenosides, and discusses their emerging role as autophagy-targeting agents, particularly in the treatment of this malignancy. Collectively, these insights offer a new perspective for the development of autophagy-based precision therapies for ovarian cancer.
Guo et al. (Sun,) studied this question.